FY2028 EPS Estimates for Oracle Boosted by Erste Group Bank

Oracle Corporation (NYSE:ORCL) – Equities research analysts at Erste Group Bank increased their FY2028 earnings per share estimates for shares of Oracle in a research note issued on Thursday, August 27th. Erste Group Bank analyst H. Engel now forecasts that the enterprise software provider will post earnings of $8.94 per share for the year, up from their previous forecast of $8.92. The consensus estimate for Oracle’s current full-year earnings is $6.49 per share.

Other research analysts have also issued reports about the stock. Oppenheimer raised their price objective on shares of Oracle from $235.00 to $275.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Wedbush cut their target price on shares of Oracle from $275.00 to $240.00 and set an “outperform” rating on the stock in a research note on Thursday, June 11th. Guggenheim reaffirmed a “buy” rating on shares of Oracle in a research report on Thursday, July 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $284.00 price target on shares of Oracle in a research note on Thursday, June 11th. Finally, Arete Research set a $255.00 price objective on Oracle and gave the company a “buy” rating in a report on Thursday, May 7th. Two research analysts have rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $262.39.

Oracle Trading Down 5.5%

ORCL opened at $140.99 on Monday. The stock has a market capitalization of $406.12 billion, a PE ratio of 24.18, a P/E/G ratio of 0.93 and a beta of 1.74. The firm’s fifty day moving average price is $139.73 and its 200 day moving average price is $160.44. The company has a debt-to-equity ratio of 3.21, a current ratio of 1.12 and a quick ratio of 1.12. Oracle has a 12-month low of $114.50 and a 12-month high of $345.72.

Oracle (NYSE:ORCL) last released its earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 EPS for the quarter, beating the consensus estimate of $1.96 by $0.15. The company had revenue of $19.18 billion during the quarter, compared to analysts’ expectations of $19.10 billion. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The business’s revenue was up 20.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.70 EPS. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS.

Institutional Investors Weigh In On Oracle

Institutional investors have recently modified their holdings of the business. Mpwm Advisory Solutions LLC grew its holdings in shares of Oracle by 76.9% during the third quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Sherman Asset Management Inc. raised its position in shares of Oracle by 5.5% during the 1st quarter. Sherman Asset Management Inc. now owns 1,054 shares of the enterprise software provider’s stock worth $155,000 after purchasing an additional 55 shares during the period. Southern Capital Advisors LLC lifted its holdings in shares of Oracle by 1.3% in the 1st quarter. Southern Capital Advisors LLC now owns 4,446 shares of the enterprise software provider’s stock worth $654,000 after purchasing an additional 57 shares during the last quarter. Global Financial Private Client LLC boosted its position in Oracle by 0.8% during the 1st quarter. Global Financial Private Client LLC now owns 7,836 shares of the enterprise software provider’s stock valued at $1,153,000 after purchasing an additional 59 shares during the period. Finally, Talisman Wealth Advisors LLC boosted its position in Oracle by 1.9% during the 2nd quarter. Talisman Wealth Advisors LLC now owns 3,086 shares of the enterprise software provider’s stock valued at $675,000 after purchasing an additional 59 shares during the period. Institutional investors own 42.44% of the company’s stock.

Insider Buying and Selling at Oracle

In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the sale, the insider directly owned 400,000 shares of the company’s stock, valued at approximately $63,664,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Friday, July 10th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, July 10th. This represents a $2.00 annualized dividend and a yield of 1.4%. Oracle’s payout ratio is presently 34.31%.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle reported $638 billion in remaining performance obligations at fiscal 2026 year-end, up 363% year over year. The backlog provides significant long-term revenue visibility, although management expects only 12% to convert to revenue within the next 12 months. Oracle Has $638 Billion of Contracted Backlog and a $430 Billion Stock
• Positive Sentiment: Analysts continue to point to Oracle’s cloud and AI growth potential. TD Cowen maintained a Buy rating despite reducing its price target to $240, while other commentary described ORCL as potentially undervalued relative to its cloud and AI opportunity. Oracle Slides as Cowen Cuts Target
• Positive Sentiment: Oracle Health expanded its Clinical AI Agent in the United States, adding automation for documentation, coding and chart-review workflows within electronic health records. The rollout could strengthen Oracle’s position in healthcare technology and support its broader AI strategy. Oracle Health Using Healthcare AI
• Neutral Sentiment: Oracle’s next quarterly report is approaching, and analysts expect another earnings beat based on its historical surprise record. Investors will focus on cloud growth, backlog conversion, capital spending and updated financing plans. Why Oracle Is Poised to Beat Earnings Estimates Again
• Negative Sentiment: Fiscal 2026 free cash flow was negative $23.7 billion as Oracle accelerated data-center investment. The company raised $43 billion in debt and expects to raise roughly $40 billion more in fiscal 2027, increasing sensitivity to higher interest rates and execution risk. Why Is Oracle Stock Down Today
• Negative Sentiment: TD Cowen’s target reduction highlighted concerns that spending is arriving before revenue, while a global bond selloff is pressuring highly leveraged AI infrastructure companies. Rising yields reduce the attractiveness of ORCL’s debt-funded expansion and future cash flows. Oracle Falls as Bond Selloff Tests AI Buildout
• Negative Sentiment: EU antitrust regulators are examining Oracle’s licensing practices, according to a Reuters source. A regulatory case similar to SAP’s could create compliance costs, concessions or restrictions on Oracle’s commercial model. Oracle Licensing Practices on EU Antitrust Radar
• Negative Sentiment: Renewed geopolitical tensions, higher global bond yields and broader technology-sector weakness further reduced investor risk appetite, adding pressure to ORCL alongside company-specific balance-sheet concerns. SoundHound AI, Fastly and Oracle Shares Plummet

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.